Pre-filled syringe

WuXi Biologics Launches First Commercial Drug Product Facility for Pre-Filled Syringes

Excerpt WuXi Biologics launched the GMP operation of its new drug product facility DP5 located in Wuxi, China. Article Summary Wuxi Biologics, a global CRDMO service company, recently opened its DP5 facility in Wuxi, China. The facility is the ninth active facility in WuXi Biologics’ global network.   A continuous and steady isolator filling system […]

Newsletter Biologics

Prestige Biopharma announces International Non-proprietary Name for PBP1510

Excerpt Prestige Biopharma Limited, announced that its first-in-class antibody PBP1510 has acquired an International Nonproprietary Name (INN) of ‘Ulenistamab’ and was placed on the INN Recommended List by the World Health Organization (WHO). Article Summary Prestige Biopharma Limited first-in-class antibody has acquired an International Nonproprietary Name (INN) of ‘Ulenistamab’. INN-Ulenistamab, which is also known as […]

MVC Covid-19

Medigen applies for Australian vaccine approval

Excerpt Medigen Vaccine Biologics Corp (高端疫苗) has applied to the Australian medicines regulator for provisional approval of its COVID-19 vaccine. Article Summary Medigen Vaccine Biologics Corp applied to Australian medicines regulator for provisional approval of the COVID-19 vaccine and has delivered the necessary documents to the Australian Therapeutic Goods Administration (TGA), but did not say […]

ILIAS Biologics signed a collaborative research agreement with JW Pharmaceutical

Excerpt JW Pharmaceutical had signed a joint research contract with bioventure ILIAS Biologics to develop a targeted exosome treatment equipped with a new low molecular weight anticancer drug. Article Summary ILIAS Biologics and JW Pharmaceutical signed a collaborative research agreement to develop an exosome-based small molecular anti-cancer treatment together.    This agreement was announced after […]

Cryoport Acquires Cell&Co BioServices

Excerpt: Cryoport, Inc. (Nasdaq: CYRX) (“Cryoport” or the “Company”), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that it has acquired Cell&Co BioServices, headquartered in Clermont-Ferrand, France with additional operations in Pont-du-Château, France. Founded in 2012, Cell&Co is a bioservices business providing biorepository, kitting, and logistics services to […]

Sanofi breaks ground at S$638 million vaccine facility in Tuas

Excerpt Sanofi broke ground on April 20 on its state-of-the-art vaccine facility in Singapore, which will allow it to quickly pivot to making new vaccines that might be needed to combat future pandemics. Article Summary French healthcare company, Sanofi, broke ground for a vaccine production facility in Singapore, which is expected to create up to […]

Lotte to buy BMS’ biologics plant in Syracuse for $160 mn

Excerpt As part of its first step toward entering the biotech industry, Lotte Group has agreed to purchase Bristol Myers Squibb’s (BMS) biologics plant in Syracuse, New York for $160 million. Article Summary South Korea’s Lotte Group announced that the group has agreed to buy Bristol Myers Squibb’s (BMS) biologics plant in Syracuse in the […]

Cytiva opening new facility in Switzerland

Excerpt Global life sciences leader Cytiva is opening a new 7400m² manufacturing facility in Grens, Switzerland on May 31, 2022. Article Summary Cytiva is opening its latest facility in Grens, Switzerland with over 7400m² in manufacturing area. The site will manufacture consumables for Xuri cell expansion systems and single use kits for the Sepax and […]

Bora Pharmaceuticals acquires Eden Biologics CDMO Assets

Excerpt Bora announced that as part of its five-year growth plan, it will initially invest $50 million USD and up to $100 million USD in the acquisition of Eden Biologics’ CDMO assets in Taiwan. Article Summary Bora Pharmaceuticals, Taiwan’s leading international contract development and manufacturing company (CDMO), has just announced the establishment of Bora Biologics […]

Recipharm completes US biologics acquisitions

Excerpt: Recipharm, a leading global contract development and manufacturing organisation (CDMO), announces the closing of its acquisitions of advanced therapy CDMO Arranta Bio and virotherapy CDMO Vibalogics.  Article Summary Recipharm announced the acquisition of Arranta Bio and Vibalogics. With this acquisition, Recipharm strengthens its presence in the Biologics market, with a particular focus on drug […]

Harbour BioMed Announces Global Out-License Agreement with AstraZeneca for CLDN18.2xCD3 Bispecific Antibody HBM7022

Excerpt: Harbour BioMed announced a global out-license agreement with AstraZeneca for CLDN18.2xCD3 bispecific antibody (HBM7022), a novel bispecific antibody generated from HBM’s HCAb Based Immune Cell Engagers (HBICE®) Platform.  Article Summary Harbour BioMed out-liscense agreement with AstraZeneca marks a major milestone in Harbour BioMed business development with the agreement and recognition by an industry-leading global […]

Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.

Excerpt: FUJIFILM Corporation announced that it has completed the acquisition of a dedicated cell therapy manufacturing facility from Atara Biotherapeutics, Inc. for USD 100 million. Article Summary FUJIFILM has acquired the facility from Atara Biotherapeutics which is located in Thousand Oaks, California. It will be operated as part of FUJIFILM Diosynth Biotechnologies’ global network, which […]